Literature DB >> 1628893

Stimulatory effect of interleukin-1 beta on the interferon-gamma-dependent HLA-DR production.

T Tomoda1, T Kurashige, T Taniguchi.   

Abstract

Expression of major histocompatibility complex (MHC) class II genes is induced by interferon-gamma (IFN-gamma) in antigen-presenting cells. When human leukaemia THP-1 and PL-21 cells were pretreated with phorbol ester, IFN-gamma-dependent induction of MHC class II gene was markedly enhanced. To elucidate the mechanism of the phenomenon, we examined the effect of cytokines which were secreted from THP-1 cells by the treatment of phorbol ester. Among those cytokines, interleukin-1 beta (IL-1 beta) had a positive effect on IFN-gamma-dependent induction of MHC class II genes. In order to rule out the possibility that different clones of THP-1 cells respond independently to IFN-gamma or phorbol ester, we showed that all independent single clones expressed MHC class II and produced IL-1 beta by IFN-gamma or phorbol ester, respectively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1628893      PMCID: PMC1421747     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Interleukin 1-dependent induction of both interleukin 2 secretion and interleukin 2 receptor expression by thymoma cells.

Authors:  J W Lowenthal; J C Cerottini; H R MacDonald
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

2.  Southern hybridization analysis of DNA polymorphism in the HLA-D region.

Authors:  H Inoko; A Ando; M Ito; K Tsuji
Journal:  Hum Immunol       Date:  1986-07       Impact factor: 2.850

3.  Depression in gene expression for poly(ADP-ribose) synthetase during the interferon-gamma-induced activation process of murine macrophage tumor cells.

Authors:  T Taniguchi; K Yamauchi; T Yamamoto; K Toyoshima; N Harada; H Tanaka; S Takahashi; H Yamamoto; S Fujimoto
Journal:  Eur J Biochem       Date:  1988-02-01

4.  Regulation of HLA class II molecule expressions by IFN-gamma. The signal transduction mechanism in glioblastoma cell lines.

Authors:  N Nezu; K Ryu; Y Koide; T O Yoshida
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

5.  Inhibition of IFN-gamma-induced Ia antigen expression on synovial fibroblasts by IL-1.

Authors:  W J Johnson; A Kelley; J R Connor; B J Dalton; P C Meunier
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

6.  Post-transcriptional control of IL-1 gene expression in the acute monocytic leukemia line THP-1.

Authors:  M Turner; D Chantry; M Feldmann
Journal:  Biochem Biophys Res Commun       Date:  1988-10-31       Impact factor: 3.575

7.  IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-gamma.

Authors:  P Ghezzi; C A Dinarello
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

8.  Transcriptional regulation of the human prointerleukin 1 beta gene.

Authors:  M J Fenton; B D Clark; K L Collins; A C Webb; A Rich; P E Auron
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

9.  Effect of cytokines on HLA-DR and IL-1 production by a monocytic tumour, THP-1.

Authors:  G Portillo; M Turner; D Chantry; M Feldmann
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

10.  Leukaemia virus infection promotes fibroblast transformation by normal BALB/c mouse DNA.

Authors:  V Krump-Konvalinkova; K J van den Berg
Journal:  Nature       Date:  1980-09-25       Impact factor: 49.962

View more
  2 in total

1.  Expression of the leptin receptor outside of bone marrow-derived cells regulates tuberculosis control and lung macrophage MHC expression.

Authors:  Maria P Lemos; Kyu Y Rhee; John D McKinney
Journal:  J Immunol       Date:  2011-08-22       Impact factor: 5.422

2.  HLA-DR antigen expression in colorectal carcinomas: influence of expression by IFN-gamma in situ and its association with tumour progression.

Authors:  K Matsushita; T Takenouchi; S Kobayashi; H Hayashi; K Okuyama; T Ochiai; A Mikata; K Isono
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.